Efficacy and Safety of Perioperative Sintilimab Plus Platinum-Based Chemotherapy for Potentially Resectable Stage IIIB Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase II Trial

Xiangyang Yu, Chujian Huang, Longde Du, Chun-Guang Wang, Yikun Yang, Xin Yu, Shengcheng Lin, Chenglin Yang, Hongbo Zhao, Songhua Cai, Zhe Wang, Lixu Wang, Xiaotong Guo, Baihua Zhang, Zhentao Yu, Jie He, Kai MaSSRN 2024 · DOI

BibTeX
@misc{yu2024efficacy,
  author = {Xiangyang Yu and Chujian Huang and Longde Du and Chun-Guang Wang and Yikun Yang and Xin Yu and Shengcheng Lin and Chenglin Yang and Hongbo Zhao and Songhua Cai and Zhe Wang and Lixu Wang and Xiaotong Guo and Baihua Zhang and Zhentao Yu and Jie He and Kai Ma and Jie He and Kai Ma},
  title = {{Efficacy and Safety of Perioperative Sintilimab Plus Platinum-Based Chemotherapy for Potentially Resectable Stage IIIB Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase II Trial}},
  year = {2024},
  doi = {10.2139/ssrn.4946296},
  howpublished = {SSRN},
}

Loading related content...

Figure